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SUMMARY
Intramuscular (1M) administration of four anaesthetic combinations were evaluated on nine cats ina repeated manner.
The anaesthetic regimens were: (i) 2 mg/kg tiletamine, 2 mg/kg zolazepam, 3.2 mg/kg ketamine and 0.8 mg/kg
xylazine (T4KX); (ii) 1 mg/kg tiletamine, 1 mg/kg zolazepam, 3.2 mg/kg ketamine and 0.8 mg/kg xylazine (T2KX);
(iii) 2 mg/kg tiletamine, 2 mg/kg zolazepam and 0.8 mg/kg xylazine (T4X); and (iv) 1 mg/kg tiletamine, 1 mg/kg
zolazepam and 0.8 mg/kg xylazine (T2X). All four combinations induced smooth recumbency within 4 minutes
following IM administration and enabled intubation. All four anaesthetic combinations caused an immediate increase
in heart rate and a dramatic decrease in respiratory rate. Pale to slight cyanotic mucous membrane was observed in
most cats, 5 minutes following administration of any of the anaesthetic combinations. The T4KX combination provided
the longest duration of anaesthesia, followed by T2KX, T4X and T2X, Time from IM injection to righting reflex,
sternal recumbency, and standing or walking, was longest after administration ofT4KX, followed by T4X, T2X and
T2KX. Quality of recovery from anaesthesia was better following T2X and T2KX administration compared to T4X and
T4KX. This study demonstrates the benefits of adding ketamine in the anaesthetic combination to reduce the tiletamine-
zolazepam component. The data in this study can be used to compare and choose an initial IM TKX induction dose
for short and non-invasive procedures in cats.
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INTRODUCTION
Tiletamine and zolazepam is a proprietary combination,
and available as Zoletil® (Virbac Pty Ltd, NSW, Austra-
lia) or Telazol® (Fort Dodge Lab., lA, USA). The use
of this combination, either alone, or with other
anaesthetics or adjuncts, has been described in cats, dogs,
horses, ruminants, exotic and wildlife species (Lin, 1996).
Intravenous (IV) and intramuscular (1M) administration
of this commercial tiletamine and zolazepam combina-
tion (T) have routinely been used in both dogs and cats
for minor procedures not lasting longer than 45 - 60
minutes at the Universiti Putra Malaysia Veterinary Hos-
pital. The typical practice involves an initial IV dose of
5 mg/kg and a top up of 113 - 112 of the initial IV dose
when needed. Often, at least a top-up dose is needed to
complete a short procedure such as a cat orchiectomy by
a senior veterinary student. Recovery is usually calmer
with less movement and vocalisation in cats than in dogs,
although some cats exhibit ataxia and repeated falling in
the cage (Chen, pers. comm.; Tracy et al., 1988).
The use of T at a dose rate of 15 mg/kg (7.5 mg/kg
tiletamine and 7.5 mg/kg zolazepam), 1M, induced satis-
factory anaesthesia for ovariectomy, with anaesthesia
time lasting approximately 50 minutes (Verstegen et al.,
1991). However, there were significant pain reactions
on injection, and recovery was often violent. Only 50%
of the cats in the above study had good muscle relax-
ation. This led to the idea of adding other anaesthetics
and adjuncts, such as ketamine and xylazine that may
improve the quality of induction, muscle relaxation and
recovery.
Ko et al. (1993) have described the use of tiletamine-
zolazepam-ketamine-xylazine (TKX) for onychectomy
and orchiectomy in cats. The TKX mixture was prepared
by adding 4 ml of ketamine (100 mg/ml) and 1 ml of
xylazine (lOa mg/ml) into a vial oflyophilized Telazol®
(250 mg tiletamine and 250 mg zolazepam). Hence, each
ml of the reconstituted combination contained 50 mg
tiletamine, 50 mg zolazepam, 80 mg ketamine and 20
mg xylazine. The mixture was administered at 0.015 ml/
lb (or 0.033 ml/kg), IM, together with 0.02 mg/lb atro-
pine. Essentially, this means that each component of the
TKX mixture was administered in the following dose rate:
1.65 mg/kg tiletamine, 1.65 mg/kg zolazepam, 2.64 mg/
kg ketamine and 0.66 mg/kg xylazine. The study reported
that the TKX combination provided rapid and smooth
induction enabling intubation. It produced excellent
muscle relaxation, with anaesthesia lasting for about 40
minutes. Recovery was smooth. The mixture also has
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the advantage of a small injection volume, thus facilitat-
ing the 1M injection and reducing pain reactions.
In 2002, Williams et al. described the use of TKX
combination for large-scale cat neutering clinics that in-
volved 7,502 feral cats. The mixture was prepared as
described by Ko et al. (1993), but administered at a higher
1M dose of 0.25 ml per adult cat (mean weight of 3.04 ±
0.8 kg). In other words, the dose rate for each compo-
nent of the TKX mixture was approximately 4.11 mg/kg
tiletamine, 4.11 mg/kg zolazepam, 6.58 mg/kg ketamine
and 1.64 mg/kg xylazine. This higher dosage enabled
placement of the identification tag, removal of the tip of
the left ear, vaccinations, medications for internal and
external parasites and surgery (ovariohysterectomy and
orchiectomy) to be performed in pregnant or non-preg-
nant females, as well as normal or cryptorchid males.
When necessary, additional top-up doses (0.05 - 0.25
ml) were administered to achieve sufficient anaesthetic
depth. This combination was found to be inexpensive,
provided predictable results, could be administered
quickly and easily in small volume, and associated with
a low mortality rate in feral cats. The mortality rate at-
tributable solely to potential anaesthetic deaths in this
study was only 0.23% (1717,502 cats), which was com-
parable to other studies, despite the large scale nature of
the clinics. Furthermore, these feral cats had unknown
history, no prior physical examination or laboratory evalu-
ation, poor body condition in some, and were often highly
stress prior to anaesthesia.
Based on the study by Williams et al. (2002), the
TKX mixture at the described higher dose rate could be
a promising anaesthetic combination alternative for small
animal practitioners in Malaysia. It is also especially
relevant for stray cats neutering campaign, where
facilities to administer an inhalant anaesthetic in the field
are usually not available. For short procedures such as
orchiectomy, superficial wound debridement and
suturing, or restraint for radiography in an otherwise
healthy cat, a lower dose rate such as that described by
Ko et al. (1993), or even lower, may be more
appropriate. Reviewing the cost for each component of
the TKX mixture, tiletamine-zolazepam contributed to
about 75% of the cost. Thus, it may be more sensible to
reduce the T component when lesser duration or
anaesthetic effect is required. Question on the benefit of
having ketamine in the TKX mixture also arose, since
tiletamine (also a dissociative agent like ketamine) is
already present in the mixture. This paper aims to de-
scribe and compare the duration of anaesthetic effects of
the TKX mixture at half the dose rate described by
Williams et al. (2002), the effect of halving the T




Nine domestic short haired cats, 8 months to 5 years of
age, 2.1 to 5.25 kg body weight were used to test all four
anaesthetic combinations, with a wash-out period of 4
days between experiments. They were judged to be
healthy based on physical examination. They were
housed in individual cages and provided dry food and
water ad libitum. Cats were fasted for 12 hours prior to
each experiment.
Anaesthetic combinations
The dose rate for each component of the TKX mixture
in the study by Williams et al (2002) was approxi-
mately 4.11 mg/kg tiletamine, 4.11 mg/kg zolazepam,
6.58 mg/kg ketamine and 1.64 mg/kg xylazine. There-
fore, to study the effect of TKX mixture at half the dose
rate described by Williams et al. (2002), the effect of
halving the T concentration, and the absence of ketamine
from these combinations, the dose rate evaluated in this
study were as follows:
(i) 2 mg/kg tiletamine with 2 mg/kg zolazepam (4 mg/
kg T), 3.2 mg/kg ketamine and 0.8 mg/kg xylazine
(T4KX).
(ii) 1 mg/kg tiletamine with 1 mg/kg zolazepam (2 mg/
kg T), 3.2 mg/kg ketamine and 0.8 mg/kg xylazine
(T2KX).
(iii) 2 mg/kg tiletarnine with 2 mg/kg zolazepam (4 mg/
kg T) and 0.8 mg/kg xylazine (T4X).
(iv) 1 mg/kg tiletamine with 1 mg/kg zolazepam (2 mg/
kg T) and 0.8 mg/kg xylazine (T2X)
The first anaesthetic combination was prepared by
adding 2.0 ml ofketamine 100 mg/ml ketamine Ketavet
100®, DEL VET Pty Ltd.) and 0.5 ml of 100 mg/ml
xylazine (Xylazil IOn", TROY Lab Pty Ltd.) into a vial
of Zoletil50 which contained 125 mg tiletamine and 125
mg zolazepam. Consequently, each millilitre of this
mixture contained 50 mg of tiletamine, 50 mg of
zolazepam, 80 mg of ketamine and 20 mg of xylazine.
The dosage of this combination was 0.04 ml/kg (that is,
0.12 ml per a 3 kg cat, is approximately half the volume
used by Williams et al., 2002).
The second anaesthetic combination was prepared
by placing 0.75 ml of the first anaesthetic mixture into a
sterile empty vial followed by 0.60 ml of 100 mg/ml
ketamine and 0.15 ml of 100 mg/ml xylazine. Thus, each
millilitre of this mixture contained 25 mg of tiletamine,
25 mg of zolazepam, 80 mg of ketamine and 20 mg of
xylazine. The dosage for this combination was 0.04 mlI
kg.
The third anaesthetic combination was prepared by
adding 2.0 ml of the provided diluent and 0.5 ml of 100
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mg/ml xylazine into a vial of Zoletil 50. Thus, each
millilitre of this mixture contained 50 mg tiletamine, 50
mg zolazepam and 20 mg xylazine. The dosage for this
combination was 0.04 ml/kg.
The fourth anaesthetic combination was prepared by
adding 0.75 ml of the third anaesthetic mixture into a
sterile empty vial followed by 0.60 ml of the provided
diluent and 0.15 ml of 10Omg/ml xylazine. Each millilitre
of this mixture contained 25 mg tiletamine, 25 mg
zolazepam and 20 mg xylazine. The dosage for this
combination was 0.04 ml/kg.
Atropine SUlphate (Atrosite, TROY Lab Pty Ltd.) at
the dosage ofO.05 mg/kg was withdrawn and mixed into
the same syringe with the TKX mixtures immediately
prior to the 1M administration.
Experimental protocols
Each cat was tested with all four anaesthetic combinations
in a repeated manner, with a four-day wash- out period
between each anaesthetic combinations. Prior to
induction, baseline heart rate, respiratory rate and rectal
temperature were determined. The drugs were
administered intramuscularly into the quadriceps muscle
and pain reactions were noted. After injection, the cats
were placed into a box and were monitored until they
became recumbent. Following recumbency, mucous
membrane colour, palbebral reflexes and jaw tone were
examined. Intubation was attempted when the jaw was
judged to be sufficiently relaxed. The cat was then placed
on left lateral recumbency. Heart rates were counted
manually by auscultation of the chest with a stethoscope.
Respiratory rates were counted based on observation of
the chest excursion. Both heart rate and respiratory rate
were determined before application of the noxious
stimuli, and at 5-minute intervals following the 1M
injection until the cat resumed sternal recumbency. Rectal
temperature was monitored using a digital thermometer
every 30 minutes for 5 hours.
Pedal reflex was elicited every 5 minutes by pinching
the interdigital toe web of the right hind foot. Superficial
noxious stimulus was simulated by clamping a fold of
skin at the ventral mid-abdominal region, and the perineal
region with an Allis tissue forcep clamped at the level of
one rachet. Deeper noxious stimulus was simulated by
using the handle of the forcep to clamp a coccygeal
vertebra at the level of one rachet. Noxious stimuli were
applied for 10 seconds each, in the order of abdominal
skin clamp, perineal clamp and tail clamp every 5 minutes.
Stimuli were removed and discontinued when positive
response was observed. Positive responses were defined
to include purposeful movement of tail or legs, lifting of
head, swallowing or vocalisation.
Time from injection to recumbency, intubation, return of
positive response to noxious stimuli, return of pedal
reflex, return of righting reflex, sternal recumbency and
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standing were determined for each cat. Duration of
intubation was taken as the time of intubation until the
cat showed coughing reflex or swallowing reflex for the
first time. Quality of recovery was scored from 1 to 5,
with the higher score indicating better recovery
(Appendix 1).
Statistical Analysis
Duration of anaesthetic effects was analysed for
difference in treatment using one-way analysis of variance
(ANOVA) and post-hoc Duncan's multiple range test.
Heart rate, respiratory rate and rectal temperature were
evaluated for difference from baseline values using
ANOVA and post-hoc Dunnett's test. A p-value of <0.05
was considered significant.
RESULTS
All four anaesthetic combinations caused mild to strong
vocalisation upon 1M injection. Retching occurred in 2,
4,3 and 7 cats following administration ofT4KX, T2KX,
T4X and T2X respectively. All four combinations induced
smooth recumbency within 4 minutes following 1M ad-
ministration, with no signs of excitement. T4KX and
T2KX induced recumbency more rapidly than T2X, while
a significant difference was not visible between T4X and
T2X (Table 1).
Pale to cyanotic mucous membrane was observed in
83 % of the cats at 5 minutes following 1M injection of
all anaesthetic combinations. At 10 minutes, 67% of cats
treated with T4KX and T2KX still showed pale to cyanotic
mucous membrane while 67% ofT2X and 89% ofT4X-
treated cats showing pink mucous membrane. At 5
minutes, strong palpebral reflex was elicited in cats
treated with T2X while T2KX, T4X and T4KX treated
cats showed slight palpebral reflex.
Tracheal intubation could be carried out in all cats
following 1M administration of all four anaesthetic
combinations. The time from injection to the ability to
intubate ranged from 4 to 5 minutes for all four
combinations. There was no significant treatment
difference in the duration of intubation.
All four treatments caused an immediate increase in
heart rate following 1M injection, gradually decreasingto
baseline by the time of sternal recumbency. All
treatments caused an immediate and dramatic decrease
in respiratory rate following anaesthetic administration,
which gradually increased to baseline values as cats
recovered. Apneustic breathing pattern was observed
within 10 minutes following all four regimens. Rectal
temperature dropped to the lowest level of of 36°C and
did not increase above 37°C within the 5 hours of
observation.
T4KX provided the longest duration of action, as
measured by the time from injection to positive response
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Table 1: Duration of anaesthetic effects following intramuscular injection of xylazine (X) combinations at high and low
concentration of tiletamine-zolazepam (T), with and without ketamine (K).
Parameters T4KX T1KX T4X T1X
TI to recumbency 2.59 ±0.09a 2.61 ±0.12a 2.72 ± 0.13 ab 3.10 ±0.2P
TI to intubation 4.30 ± 0.33 I 3.84 ±0.19" 4.23 ±0.26a 4.34 ± 0.30'
Duration of intubation 39.06 ± 10.75 I 24.10 ± 3.99 a 29.28 ± 4.30 I 21.50 ± 2.93 a
TI to abdominal skin clamp response 59.42 ± 4.75 b 42.64 ± 2.44 I 44.13 ± 2.31" 34.56 ± 3.85 a
TI to perineal clamp response 48.07 ± 3.90 c 34.58 ± 1.12 b 33.12 ± 3.44 b 21.51 ± 2.35 a
TI to tail clamp response 43.83 ± 2.80 c 32.18 ± 1.47 b 29.90 ± 2.26 b 16.51 ± 2.12 a
TI to pedal reflex 46.40 ± 5.81 b 40.05 ± 4.38 ab 35.06 ± 3.59 ab 27.15 ±2.86a
TI to righting reflex 67.61 ± 6.89 b 49.20 ±3.74a 54.62 ± 3.28 ab 50.59 ± 6.39 a
TI to sternal recumbency 71.15 ± 7.78 b 51.32 ± 3.76 a 56.73 ± 3.69 ab 53.71 ± 4.36 a
TI to standing/walking 76.46 ± 8.30 b 56.86 ± 3.96 a 58.36 ± 3.49 a 55.31 ±4.30a
Data are expressed as mean ± standard error, n = 9.
Values with different superscripts differ significantly (p < 0.05).
11 - time (minute) from injection
T4KX - 2 mglkg tiletamine with 2 mg/kg zolazepam, 3.2 mg/kg ketamine and 0.8 mglkg xylazine.
T2KX - 1 mg/kg tiletamine with 1 mglkg zolazepam, 3.2 mg/kg ketamine and 0.8 mg/kg xylazine.
T4X - 2 mg/kg tiletamine with 2 mg/kg zolazepam and 0.8 mg/kg xylazine.
T2X - 1 mg/kg tiletamine with 1 mg/kg zolazepam and 0.8 mg/kg xylazine.
to abdominal skim clamp, perineal clamp and tail clamp
(fable O. No differences were observed between T2KX
and T4X, while T2X provided the shortest duration of
action. A similar trend was observed in the time of
injection to return of pedal reflex.
The time from injection to righting reflex was longest
following adminis!I"ation ofT 4KX, followed by T4X,T2X
and T2KX. Similar trends were observed in the time from
injection to sternal recumbency and standing/walking.
The majority of the cats showed good and quiet recovery
following T2KX (78% scored 3) and T2X (44% scored
4). Cats were more ataxic and made more attempts to
stand following T4KX (78% scored 2) and T4X (89%
scored 2).
DISCUSSION
This study describes the effect of 1M administration of
T4KX at approximately half the dose rate used by
Williams et al. (2002), the effect of reducing the T
concentration to half (T2KX), and the absence ofketamine
from the mixtures (T4X and T2X). This study
demonstrates that all four anaesthetic combinations can
be administered 1M to achieve rapid recumbency within
4 minutes. All four combinations provided adequate jaw
relaxation and anaesthetic depth to enable tracheal
intubation that lasted for at least 21.5 ± 8.78 minutes,
which is the shortest duration of anaesthesia, following
T2X.
All four combinations induced anaesthesia that
enabled painful procedures equivalent to tail clamping
to be carried out for at least 16.51 ±6.35 minutes (the
shortest duration, following T2X), to as long as 43.83
8.4 minutes (the longest duration, following T4KX).
Reducing the T concentration to half (T2KX) or absence
of ketamine from the mixture (T 4X) decreased the
duration of action (absence of positive response to
noxious stimuli) to the same degree in both combinations.
Time to righting reflex and sternal recumbency were
significantly decreased by reducing the T concentration
(T2KX and T2X), but not in the absence of ketamine
(f4X). These results suggest that the addition of 3.2 mg/
kg ketamine to T2X has the advantage of providing a
similar duration of anaesthetic effect to that of doubling
the T concentration to T4X, without increasing the time
to recovery. Furthermore, the quality of recovery was
better following T2KX and the cost is also lower when
compared to T4X (Appendix 2).
The poorer recovery score and tendency for longer
recovery time in both T4X and T4KX was likely due to
the higher dosage of tiletamine and zolazepam in these
regimens compared to T2KX and T2X treatments. The
recovery time in cats is known to be prolonged due to
the longer plasma half-life of tiletamine and zolazepam
in cats (Lin, 1996). The presence of ketamine in T2KX
may have added to the initial anaesthetic effect, thus
providing an equivalent duration of effective anaesthetic
effect as in T4X treatment. However, since the action of
ketamine is shorter than tiletamine (Lin, 1996), this
probably explain the short recovery time using T2KX.
This further supports the advantage of adding ketamine
to reduce the T component in the mixture.
The pale to slight cyanotic mucous membrane
observed in some of the cats during the first 5 - 10 minutes
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following anaesthetic administration is likely a reflection
of vasoconstriction caused by xylazine, and possibly
respiratory depression caused by the combined effects
of xy lazine, tiletamine and ketamine. A similar side effect
was also reported in a study using the TKX mixture at a
dose rate double that of T4KX, where haemoglobin
saturation (Sp02) fell below 90% at least once in 88% of
female cats (Cistola et al., 2004). Decreased Sp02 values
could be due to vasoconstriction, low inspiratory oxygen
tension (breathing of room air), hypo ventilation,
ventilation-perfusion mismatched or shunting. Since cats
in the present study and that by Cistola et al. (2004) were
breathing room air, oxygen supplementation may have
helped to correct this side effect. In our study, the greatest
respiratory depression was observed during the initial
anaesthetic period, indicating greater central nervous
depression. Perhaps, a lower induction dosage of TKX
may reduce the respiratory depression; however this
practice would likely require more topping up ofTKX to
maintain anaesthesia.
The increased heart rate following drug
administration could be due to sympathetic stimulation
by the pain from 1M injection, tiletamine and ketamine,
as well as the vagolytic effect of atropine. The
cardiovascular stimulating effect of tiletamine and
ketamine are well known (Tracy et al., 1988; Hellyer et
al., 1988; Lin, 1996), however, a significant increase in
heart rate was not documented in previous studies on TKX
combination (Ko et al., 1993; Cistola et al., 2004). An
anticholinergic drug was not used in the study by Cistola
et al. (2004) and increase heart rate was not observed.
Atropine was included in our anaesthetic protocol with
the intention of controlling ptyalism. Since significant
and sustained tachycardia was observed in the present
study, it is advisable not to administer atropine routinely
in clinical cases, but to reserve for use only when
necessary. This would also reduce the volume of drug to
be injected and may help to reduce the pain reactions
associated with the 1M injection.
Body temperature decreased significantly in all cats
following all four anaesthetic mixtures, indicating the loss
of ability to regulate temperature during general
anaesthesia (Harvey, 2002). However, the drop in
temperature was not excessive (> 36%), and should not
inflict a significant detrimental effect.
This study was limited by the fact that the noxious
stimuli were simulated using skin and tail clamp, and not
by actual surgery. Actual skin incisions and surgical
procedures may provide more realistic descriptions of
the utility of the anaesthetic regimens. Nevertheless, the
results of this study can be used as a guide to compare
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and choose the initial TKX dosage for short and non-
invasive procedures. This study also demonstrates the
benefits of adding ketamine to reduce the T concentration,
and the utility of all four combinations as induction agents
that enable intubation. Future studies should be designed
to evaluate their utility in clinical cases involving actual
procedures.
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Appendix 1: Descriptions for scoring quality of recovery
1 - Violent excitement
2 - Ataxic before standing, several attempts to rise, very
ataxic once standing
3 - Quiet recovery, several attempts to stand, ataxic when
standing or walking
4 - Good, quiet recovery, stand on first attempt, mild
ataxia when standing or walking
5 - Good, quiet recovery, stand on first attempt, no ataxia
when standing or walking
Appendix 2: Cost of anaesthetics per kg body weight
Anaesthetic T4KX TzKX T4X TzX
component
Tiletamine RM 0.64 RM 0.32 RM 0.64 RM 0.32
-zolazepam (T)
Ketamine (K) 0.10 0.10
Xylazine (X) 0.05 0.05 0.05 0.05
Total cost 0.79 0.47 0.69 0.37
per kg body
weight
Note: Calculation of cost based on price list as of October 2005.
